Rubropunctatin exhibits anti-inflammatory, immunosuppressive, antioxidant, and antitumor activities; it shows selective tumoricidal effects against human gastric carcinoma BGC-823 cells without significant toxicity to normal epithelial GES-1 cells; it induces apoptosis in BGC-823 cells in a dose- and time-dependent manner; it demonstrates DPPH radical scavenging activity, inhibits superoxide radical generation, and possesses ferric reducing activity; it reduces tumor volume and weight in BGC-823 xenograft nude mice; it inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice.